Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor-Reference-Cited by-同舟云学术

Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor

Published:2017-08-01 Issue:1 Volume:8 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Roymans Dirk,Alnajjar Sarhad S,Battles Michael B^ORCID,Sitthicharoenchai Panchan,Furmanova-Hollenstein Polina,Rigaux Peter,Berg Joke Van den,Kwanten Leen,Ginderen Marcia Van,Verheyen Nick,Vranckx Luc,Jaensch Steffen,Arnoult Eric,Voorzaat Richard,Gallup Jack M.,Larios-Mora Alejandro,Crabbe Marjolein,Huntjens Dymphy,Raboisson Pierre,Langedijk Johannes P.,Ackermann Mark R.,McLellan Jason S,Vendeville Sandrine,Koul Anil

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-017-00170-x.pdf

Reference77 articles.

1. Hall, C. B. et al. The burden of respiratory syncytial virus in young children. N. Engl. J. Med. 360, 588–598 (2009).

2. Nair, H. et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375, 1545–1555 (2010).

3. Rudan, I. et al. Epidemiology and etiology of childhood pneumonia. Bull. World Health Organ. 86, 408–416 (2008).

4. Falsey, A. R. et al. Respiratory syncytial virus infection in the elderly and high-risk adults. N. Engl. J. Med. 352, 1749–1759 (2005).

5. Simoes, E. A. F. Respiratory syncytial virus infection. Lancet 354, 847–852 (1999).

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new mechanism of respiratory syncytial virus entry inhibition by small-molecule to overcome K394R-associated resistance;mBio;2024-09-11

2. Direct-acting antivirals for RSV treatment, a review;Antiviral Research;2024-09

3. Respiratory syncytial virus infections in adults: a narrative review;The Lancet Respiratory Medicine;2024-09

4. Systematic Review of the Efficacy and Safety of RSV‐Specific Monoclonal Antibodies and Antivirals in Development;Reviews in Medical Virology;2024-08-29

5. Discovery of gem-Dimethyl-hydroxymethylpyridine Derivatives as Potent Non-nucleoside RSV Polymerase Inhibitors;Journal of Medicinal Chemistry;2024-08-06